ArticleScientific reports2025
NiO@rGO nanohybrids triggered cytotoxicity via oxidative stress, cell cycle arrest, and apoptosis pathways.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- NiCo₂O₄ nanoparticles as chemosensitizers: enhancing doxorubicin-ınduced ıntrinsic apoptosis in A549 and MCF-7 cells.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
NiO@rGO nanohybrids have received copious attention in nanomedicine, energy, and environmental research because of their superior physicochemical properties compared to either of their components alone. The increasing applications of NiO@rGO nanohybrids have elicited concerns regarding human and environmental health risks. A lot of research has been done on the toxicity of simple forms of nanoparticles (e.g., NiO or rGO only), but limited work has been done about the toxicological effects of hybrid or composite forms of such nanoscale materials. Here, we designed this research to examine cytotoxicity, oxidative stress, and apoptosis responses of hydrothermally synthesized NiO@rGO nanohybrids on normal rat kidney cells (NRK-52E). The XRD, TEM, SEM, and EDS characterization data confirm the preparation of excellent-quality NiO@RGO nanohybrids of about 24-28 nm sizes with high purity, where crystalline NiO nanoparticles were tightly anchored on RGO sheets. The MTT, trypan blue, and morphology data showed that NiO@rGO nanohybrids induce cytotoxic effects in NRK-52E cells in an approach that was reliant on time and dosage. It was also observed that NiO@rGO nanohybrids generated oxidative stress in NRK-52E cells, as shown by increased reactive oxygen species (ROS) and decreased glutathione levels. The NiO@rGO nanohybrids further induced apoptosis in NRK-52E cells, obvious by chromosome condensation, caspase-3 activation, apoptotic bodies generation, and cell cycle arrest. Besides, NiO@rGO nanohybrids generate significant cytotoxicity and ROS elevation in human lung cancer cells (A549) and human umbilical vein endothelial cells (HUVECs), suggesting that the cytotoxicity of NiO@rGO nanohybrids was not cell-specific. Overall, present data suggested that NiO@rGO nanohybrids induced cytotoxicity in mammalian cell lines through the ROS and apoptosis pathways. This work warrants further in-depth in vivo toxicological investigation of NiO@rGO nanohybrids before their applications in the environment, energy, and biomedicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.